Arkolith/Insider Trading/LXEO/Form 4

Townsend Richard Nolan

Chief Executive Officer, DirectorLexeo Therapeutics, Inc. (LXEO) · full profile →Form 4 · filed Oct 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$118K
Net Open-Market Flow
-$118K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 17, 2025Sell(S)13K$8.94$116K242K
Oct 17, 2025Sell(S)148$9.56$1K242K
Oct 15, 2025Grant(A)33K—$0255K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001995218-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML